|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 8.400 USD | +7.97% |
|
+6.60% | +38.16% |
| 10-19 | Exagen Insider Sold Shares Worth $269,791, According to a Recent SEC Filing | MT |
| 09-20 | Exagen Inc.(NasdaqGM:XGN) dropped from S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 188M | - | - | - | ||
| 117B | |||||
| 97.42B | |||||
| 59.22B | - | ||||
| 29.03B | |||||
| 26.86B |
- Stock Market
- Stocks
- XGN Stock
- Charts Exagen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
